1. The Use of Vaccines in Adult Patients With Renal Disease
Mara Dinits-Pensy, MD, Graeme N. Forrest, MD, Alan S. Cross, MD, Michael K. Hise, MD 
American Journal of Kidney Diseases 
Volume 46, Issue 6, Pages (December 2005)
DOI: /j.ajkd
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
Adjusted mortality rates in dialysis patients after the first pneumonia event. Data obtained from 194,374 incident dialysis patients, 1996 to Rates adjusted for age, sex, race, primary diagnosis, and vintage. Patients without pneumonia were used as the reference cohort. Data from USRDS 2004 Annual Data Report. 1
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

3. Fig 2
Adjusted cardiovascular event rates in dialysis patients after the first pneumonia event. Data obtained from 78,262 incident dialysis patients, 1996 to Rates adjusted for age, sex, race, primary diagnosis, and vintage. Patients without pneumonia were used as the reference cohort. Data from USRDS 2004 Annual Data Report. 1
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

4. Fig 3
Hospital admission rates for septicemia during the first year on peritoneal dialysis (PD) or hemodialysis (HD), 1991 to Septicemia rates in patients on hemodialysis therapy continue to increase, whereas rates in peritoneal dialysis patients have remained stable and are consistently lower. Rates adjusted for age, sex, race, and primary diagnosis. Data from USRDS 2004 Annual Data Report.1
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions